Single Cell Analysis Market Size, Share & Trends Analysis Report By Application (IVF, Cancer, Immunology, Stem Cell, Non-invasive Prenatal Diagnosis), By Product, By Region, And Segment Forecasts, 2018 - 2025

Industry Insights

The global single cell analysis market size was valued at USD 1.4 billion in 2016 and is likely to expand at a CAGR of 17.3% over the forecast period. Widening applications of single cell analysis in genomics, transcriptomic, proteomics, and epigenetic studies are anticipated to propel market growth.

Currently, around 1,300 clinical trials are in process to assess the efficacy of single cell analysis in effective diagnosis of various types of cancer and infections including HIV, hepatitis, and Influenza through immunology. Similarly, major players are investing in research and development (R&D) to assess applications of single cell analysis in stem cell transplant procedures to increase success rates of these procedures. Introduction of advanced devices that enable easy transcriptomic and proteomics procedures is triggering adoption of single cell analysis techniques.

Government promotional programs and initiatives such as Health Japan 21 and Germany’s Preventive Health Care Act are expected to propel market growth over the forecast period. In addition, factors such as high prevalence of neurological disorders and rise in disease diagnosis propel market growth.

However, high costs associated with instruments restrain market expansion. Demand for analytical tools and technical advancements is leading to introduction of high-end machinery. Innovations lead to newly developed features like high sensitivity, accuracy, and efficacy by utilizing scarce samples.

These advancements are expected to increases overall cost of instrument. Polymerase Chain Reaction (PCR)-based assays, stem cell therapies, and other single cell based analysis involve high therapeutic costs due to the expenses incurred by the instruments used. Thus, high cost of devices is expected to impede market growth in developing and lower income countries.

Product Type Insights

The consumables segment accounted for the largest revenue share in 2016, with existing players adopting various strategies to boost sales. Constant demand and repeat purchase result in continuous revenue generation. Moreover, demand for specialty chemicals and various assays for therapeutic purposes and clinical research is augmenting the consumables segment. Installation of new instruments and replacement of old ones has also generated significant revenue for consumables.

The instruments segment can be broadly bifurcated into manual and automated, with instruments such as microscopes, haemocytometers, PCR systems, cell microarrays, and flowcytometers within these two categories. Automated instruments outweigh the disadvantages of manually operated variants and therefore their penetration is greater in the market.

Application Type Insights

Rising awareness is aiding adoption of analytical techniques in the global market for single cell analysis. Cancer is the largest revenue generating segment owing to high prevalence, initiatives for early detection, and increasing awareness regarding commercially available cancer diagnostics.

Statistics by Cancer Research UK indicate that in 2012, 14.1 million new cancer cases were reported, leading to 8.2 million deaths worldwide. Hence, to avoid risks associated with cancer therapy, single cell analysis techniques are being adopted in cancer diagnosis.

Over the past few years, it has been observed that study of immunogenicity of cells is an essential factor in disease diagnosis. Immunology studies aid in early detection of therapeutic complications and increase efficiency of the treatment. Furthermore, invasion of metabolic activities of single cells is increasing adoption of its analytical tools propelling growth of immunology segment.

Regional Insights

The global single cell analysis market was dominated by North America in 2016, followed by Europe. Dominance of North America was mainly attributed to establishment of new biotechnology and biopharmaceutical companies in the region. Moreover, adoption of gene-based analysis techniques by these companies and research laboratories is augmenting regional market growth.

Asia Pacific is expected to witness the fastest growth during the forecast period, attributed to numerous government initiatives undertaken to improve healthcare infrastructure, availability of skilled professionals to operate advanced analytical instruments, and rising healthcare expenditure. In addition, presence of a considerably large target population, escalating demand for genetic analysis, and flourishing medical tourism industry are likely to augment market growth.

Single Cell Analysis Market Share Insights

Companies in this market are implementing strategies such as mergers and acquisitions to expand their product portfolio and strengthen their position in the industry. The partnership between Illumina, Inc. and Bio-Rad Laboratories, Inc. is one such example of strategies implemented by leading players.

Major industry participants include Thermo Fisher Scientific, Inc.; Illumina, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Merck Millipore GmbH; Beckman Coulter, Inc. (U.S.); and Becton, Dickinson and Company (U.S.).

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global single cell analysis market report on the basis of product type, application type, and region:

• Product Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Consumables

    • Reagents

    • Assay Kits

    • Other Consumables

  • Instruments

    • Manual Instruments

    • Microscopes

    • Haemocytometers

    • Automated Instruments

    • Flowcytometers

    • Next Generation Sequencing

    • PCR Systems

    • High-content Screening System

    • Cell Microarrays

    • Automated Cell Counters

• Application Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Cancer

  • Immunology

  • Neurology

  • Stem Cell

  • Non-invasive Prenatal Diagnosis

  • In-vitro Fertilization

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • China

    • India

  • Latin America

    • Mexico

    • Brazil

  • Middle East & Africa

    • South Africa